BRD4 and lung carcinoma: Of significance, the dBET6‐containing formulations suppressed lung cancer cell growth, as evaluated by Cell Counting Kit‐8 (CCK‐8) and colony formation assays (Figure 3A,B), implying that the BRD4 degradation effectively inhibited the cancer cell growth.